Literature DB >> 16933012

Accumulation of 8-nitroguanine in the liver of chronic hepatitis C patients without sustained virological response after completion of interferon therapy.

Masahiko Kaito, Shinichiro Horiike, Hideaki Tanaka, Naoki Fujita, Yukihiko Adachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16933012     DOI： 10.1007/s00535-006-1832-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  8 in total

Review 1.  Radical causes of cancer.

Authors:  S Perwez Hussain; Lorne J Hofseth; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

2.  Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

Authors:  A Kasahara; N Hayashi; K Mochizuki; M Takayanagi; K Yoshioka; S Kakumu; A Iijima; A Urushihara; K Kiyosawa; M Okuda; K Hino; K Okita
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

3.  Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

Authors:  K Ikeda; S Saitoh; Y Arase; K Chayama; Y Suzuki; M Kobayashi; A Tsubota; I Nakamura; N Murashima; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

4.  Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.

Authors:  Masafumi Ikeda; Shigetoshi Fujiyama; Motohiko Tanaka; Michio Sata; Tatsuya Ide; Hiroshi Yatsuhashi; Hiroshi Watanabe
Journal:  J Gastroenterol       Date:  2005-02       Impact factor: 7.527

5.  Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection.

Authors:  Yasuji Arase; Kenji Ikeda; Akihito Tsubota; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Masahiro Kobayashi; Norio Akuta; Takashi Someya; Tetsuya Hosaka; Hitomi Sezaki; Mariko Kobayashi; Hiromitsu Kumada
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

6.  Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.

Authors:  Shinichiro Horiike; Shosuke Kawanishi; Masahiko Kaito; Ning Ma; Hideaki Tanaka; Naoki Fujita; Motoh Iwasa; Yoshinao Kobayashi; Yusuke Hiraku; Shinji Oikawa; Mariko Murata; Jinyan Wang; Reiji Semba; Shozo Watanabe; Yukihiko Adachi
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

Authors:  S Nishiguchi; T Kuroki; S Nakatani; H Morimoto; T Takeda; S Nakajima; S Shiomi; S Seki; K Kobayashi; S Otani
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.